Brooke-Spiegler syndrome

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home Genes Leukemias Solid Tumors Cancer-Prone Deep Insight Case Reports Journals Portal Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Brooke-Spiegler syndrome

Written	2011-11	Jean-Loup Huret
		Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

(Note : for Links provided by Atlas : click)

Identity

Other names Ancell-Spiegler cylindromas
Familial cylindromatosis
Turban tumor syndrome
Brooke-Fordyce trichoepitheliomas
Multiple familial trichoepitheliomas
Atlas_Id 10097

Genes implicated in CYLD
Note Familial cylindromatosis/Turban tumor syndrome and multiple familial trichoepitheliomas were considered as separate diseases; it is now known that they are allelic diseases and represent two ends of the Brooke-Spiegler syndrome spectrum (Welch et al., 1968; Young et al., 2006). Familial cylindromatosis/Turban tumor syndrome is characterized by cylindromas and multiple familial trichoepitheliomas by trichoepitheliomas as the only tumor type.

Inheritance Autosomal dominant disease, with high penetrance, and penetrance increasing with age, and variable expressivity. Female predominance (8M/13F).

Clinics

Phenotype and clinics Brooke-Spiegler syndrome is a skin appendage tumors syndrome, with development of cylindromas, spiradenomas, and/or trichoepitheliomas, from late childhood, and gradually increase in size and numbers.
Cylindromas are dermal papules and nodules. They grow slowly. They classically occur on the scalp and occasionally on the face, trunk or extremities. Scalp cylindromas can become numerous and may eventually cover the entire scalp ("turban tumors"). They present as multinodular, well circumscribed nest of undifferentiated basaloid cells in a charateristic "jigsaw puzzle" pattern.
Spiradenomas are usually located on the face, the trunk and extremities. A frequent symptom is pain. They present as bluish nodules of basaloid cells in the dermis, with presence of numerous lymphocytes, in contrast to what is found in cylindromas. There are hybrid forms between cylindromas and spiradenomas.
Trichoepitheliomas typically occur on the face, predominantly on the nose, the nasolabial folds, and the lips. Trichoepitheliomas derive from the trichoblast (i.e. the folliculo-sebaceous-apocrine germ). They are small skin-colored papules or nodules, with nests of basaloid cells forming cysts containing horn cells (with keratin) (Lee et al., 2005; Kim et al., 2007; Blake and Toro, 2009).

Neoplastic risk Apart from cylindromas, spiradenomas, and trichoepitheliomas, patients with Brooke-Spiegler syndrome are also at risk of basal cell carcinomas and syringomas. Cylindromas may transform into cylindrocarcinomas, which are locally aggressive and metastasize. Spiradenomas may transform into spiradenocarcinomas or show sarcomatous differentiation. An increased risk of developing tumors of the salivary glands has also been described (basal-cell adenomas and adenocarcinomas of the parotid glands and minor salivary glands) (Lee et al., 2005; Kim et al., 2007; Blake and Toro, 2009).

Treatment Removal by surgery. Salicylic acid is efficient in only a small proportion of tumours.

Genes involved and Proteins

Note Although most cases of Brooke-Spiegler syndrome have been described with a mutation in CYLD (Bignell et al., 2000; 68 unique CYLD mutations have been identified so far), some cases do not have mutations or loss of heterozygosity in CYLD gene (Ponti et al., 2011).
Transcriptome of the tumors: cylindroma and spiradenoma tumours showed similar profile, with LOH at 16q found in the majority of the tumours, and upregulation of TRKB, TRKC, NT3/NT4, and BDNF, and ERK and BCL2 as well, while the transcriptome of trichoepitheliomas was different (Rajan et al., 2011).

Gene Name CYLD

Location 16q12.1

Protein
Description Member of the deubiquitinase family. Cleaves Lys-63-linked polyubiquitin chains. Negative regulator of NF-kappaB and JNK signalings. Binds NEMO, TRAF2 and TRAF6 and deubiquitinates them. Participates in antimicrobial defense and inflammation (Review in Courtois, 2010).

Mutations
Germinal Most of the mutations produce large deletions of the protein.

Somatic Different types of somatic mutations in benign and malignant tumors (Kazakov et al., 2010).

Bibliography

Identification of the familial cylindromatosis tumour-suppressor gene.

Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van Den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S.

Nat Genet. 2000 Jun;25(2):160-5.

PMID 10835629

Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Blake PW, Toro JR.

Hum Mutat. 2009 Jul;30(7):1025-36. (REVIEW)

PMID 19462465

CYLD (cylindromatosis (turban tumor syndrome)).

Courtois G.

Atlas Genet Cytogenet Oncol Haematol. May 2010. URL: http://AtlasGeneticsOncology.org/Genes/CYLDID40232ch16q12.html

Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors.

Kazakov DV, Schaller J, Vanecek T, Kacerovska D, Michal M.

J Cutan Pathol. 2010 Aug;37(8):886-90. Epub 2010 Feb 4.

PMID 20132422

Brooke-Spiegler syndrome.

Kim C, Kovich OI, Dosik J.

Dermatol Online J. 2007 Jan 27;13(1):10.

PMID 17511943

Genetics of skin appendage neoplasms and related syndromes.

Lee DA, Grossman ME, Schneiderman P, Celebi JT.

J Med Genet. 2005 Nov;42(11):811-9. (REVIEW)

PMID 16272260

Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.

Ponti G, Nasti S, Losi L, Pastorino L, Pollio A, Benassi L, Giudice S, Bertazzoni G, Veratti E, Azzoni P, Scarra GB, Seidenari S.

J Cutan Pathol. 2011 Nov 12. doi: 10.1111/j.1600-0560.2011.01813.x. [Epub ahead of print]

PMID 22077640

Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.

Rajan N, Elliott R, Clewes O, Mackay A, Reis-Filho JS, Burn J, Langtry J, Sieber-Blum M, Lord CJ, Ashworth A.

Oncogene. 2011 Oct 13;30(41):4243-60. doi: 10.1038/onc.2011.133. Epub 2011 May 9.

PMID 21552290

Ancell-Spiegler cylindromas (turban tumours) and Brooke-Fordyce Trichoepitheliomas: evidence for a single genetic entity.

Welch JP, Wells RS, Kerr CB.

J Med Genet. 1968 Mar;5(1):29-35.

PMID 5653864

CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes.

Young AL, Kellermayer R, Szigeti R, Teszas A, Azmi S, Celebi JT.

Clin Genet. 2006 Sep;70(3):246-9.

PMID 16922728

Citation

This paper should be referenced as such :

Huret, JL

Brooke-Spiegler syndrome

Atlas Genet Cytogenet Oncol Haematol. 2012;16(4):304-305.

Free journal version : [ pdf ] [ DOI ]

On line version : http://AtlasGeneticsOncology.org/Tumors/BrookeSpieglerID10097.html

REVIEW articles automatic search in PubMed

Last year articles automatic search in PubMed

Home Genes Leukemias Solid Tumors Cancer-Prone Deep Insight Case Reports Journals Portal Teaching

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.

Other names	Ancell-Spiegler cylindromas
	Familial cylindromatosis
	Turban tumor syndrome
	Brooke-Fordyce trichoepitheliomas
	Multiple familial trichoepitheliomas
Atlas_Id	10097
Genes implicated in	CYLD
Note	Familial cylindromatosis/Turban tumor syndrome and multiple familial trichoepitheliomas were considered as separate diseases; it is now known that they are allelic diseases and represent two ends of the Brooke-Spiegler syndrome spectrum (Welch et al., 1968; Young et al., 2006). Familial cylindromatosis/Turban tumor syndrome is characterized by cylindromas and multiple familial trichoepitheliomas by trichoepitheliomas as the only tumor type.
Inheritance	Autosomal dominant disease, with high penetrance, and penetrance increasing with age, and variable expressivity. Female predominance (8M/13F).

Phenotype and clinics	Brooke-Spiegler syndrome is a skin appendage tumors syndrome, with development of cylindromas, spiradenomas, and/or trichoepitheliomas, from late childhood, and gradually increase in size and numbers. Cylindromas are dermal papules and nodules. They grow slowly. They classically occur on the scalp and occasionally on the face, trunk or extremities. Scalp cylindromas can become numerous and may eventually cover the entire scalp ("turban tumors"). They present as multinodular, well circumscribed nest of undifferentiated basaloid cells in a charateristic "jigsaw puzzle" pattern. Spiradenomas are usually located on the face, the trunk and extremities. A frequent symptom is pain. They present as bluish nodules of basaloid cells in the dermis, with presence of numerous lymphocytes, in contrast to what is found in cylindromas. There are hybrid forms between cylindromas and spiradenomas. Trichoepitheliomas typically occur on the face, predominantly on the nose, the nasolabial folds, and the lips. Trichoepitheliomas derive from the trichoblast (i.e. the folliculo-sebaceous-apocrine germ). They are small skin-colored papules or nodules, with nests of basaloid cells forming cysts containing horn cells (with keratin) (Lee et al., 2005; Kim et al., 2007; Blake and Toro, 2009).
Neoplastic risk	Apart from cylindromas, spiradenomas, and trichoepitheliomas, patients with Brooke-Spiegler syndrome are also at risk of basal cell carcinomas and syringomas. Cylindromas may transform into cylindrocarcinomas, which are locally aggressive and metastasize. Spiradenomas may transform into spiradenocarcinomas or show sarcomatous differentiation. An increased risk of developing tumors of the salivary glands has also been described (basal-cell adenomas and adenocarcinomas of the parotid glands and minor salivary glands) (Lee et al., 2005; Kim et al., 2007; Blake and Toro, 2009).
Treatment	Removal by surgery. Salicylic acid is efficient in only a small proportion of tumours.

Protein
Description	Member of the deubiquitinase family. Cleaves Lys-63-linked polyubiquitin chains. Negative regulator of NF-kappaB and JNK signalings. Binds NEMO, TRAF2 and TRAF6 and deubiquitinates them. Participates in antimicrobial defense and inflammation (Review in Courtois, 2010).

Mutations
Germinal	Most of the mutations produce large deletions of the protein.
Somatic	Different types of somatic mutations in benign and malignant tumors (Kazakov et al., 2010).

REVIEW articles	automatic search in PubMed
Last year articles	automatic search in PubMed